Science Explorer Interactive view Map
Institution · Brussels · Belgium

Rijksinstituut voor Ziekte- en Invaliditeitsverzekering

Research works
62
▲ 41% vs 2013–17
Citations
703
11.3 per fractional work
Top-10% rate
9.8%
record average 16.5%
Open access
47%
world 28%

Not ranked overall: Rijksinstituut voor Ziekte- en Invaliditeitsverzekering is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.45× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.13× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 3.86× its world share, 1 worksImmunology and Micro…Neuroscience: 0.11× its world share, 0 worksNeuroscienceChemical Engineering: 0.87× its world share, 0 worksChemical EngineeringComputer Science: 0.18× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.23× its world share, 0 worksEarth and Planetary …Engineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.74× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.09× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.10× its world share, 0 worksPhysics and AstronomyHealth Professions: 6.02× its world share, 2 worksHealth ProfessionsMedicine: 1.61× its world share, 5 worksMedicineDecision Sciences: 0.11× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 6.06× its world share, 2 worksEconomics, Econometr…Psychology: 0.42× its world share, 0 worksPsychologySocial Sciences: 2.01× its world share, 4 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Economics, Econometrics and Finance, 6.1×. Every wedge is a field page.

Which keywords describe research at Rijksinstituut voor Ziekte- en Invaliditeitsverzekering?

By fractional works in all years, weighted toward what it does more of than the world: Quality of Life, Public Health, Primary Care, Cost-effectiveness Analysis, Health Utility Measures, Healthcare Policy, Pharmaceutical Industry and Drug Development Costs.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life8▲ 9.3×13 topics
  2. Public Health5▲ 6.2×17 topics
  3. Primary Care4▲ 17×8 topics
  4. Cost-effectiveness Analysis4▲ 79×1 topic
  5. Health Utility Measures4▲ 79×1 topic
  6. Epidemiology3▲ 1.26×24 topics
  7. Healthcare Policy3▲ 58×2 topics
  8. Pharmaceutical Industry3▲ 107×2 topics
  9. Drug Development Costs3▲ 167×1 topic
  10. Generic Drugs3▲ 167×1 topic
  11. Quality Improvement3▲ 20×6 topics
  12. Social Determinants of Health2▲ 17×3 topics
  13. Inequalities2▲ 95×1 topic
  14. Universal Health Coverage2▲ 95×1 topic
  15. Clinical Trials2▲ 5.3×6 topics
  16. Clinical Guidelines2▲ 9.8×4 topics
  17. Economic Development2▲ 4.3×3 topics
  18. Risk Factors2▲ 2.8×11 topics
  19. Patient Engagement2▲ 29×2 topics
  20. Self-Determination2▲ 180×1 topic
  21. Universal Design for Learning2▲ 180×1 topic
  22. Chronic Disease Management2▲ 16×3 topics
  23. Adverse Drug Reactions1▲ 35×2 topics
  24. Off-Label Drug Use1▲ 60×1 topic
  25. Pediatric Pharmacokinetics1▲ 60×1 topic
  26. Guideline Development1▲ 67×1 topic
  27. Healthcare Communication1▲ 26×2 topics
  28. Practice Recommendations1▲ 67×1 topic
  29. Public Health Policy1▲ 11×3 topics
  30. Quality Assessment1▲ 10×2 topics
  31. Quality of Care1▲ 25×2 topics
  32. Choosing Wisely1▲ 89×1 topic
  33. Low-Value Care1▲ 89×1 topic
  34. Patient Safety1▲ 14×4 topics
  35. Cyclodextrins1▲ 70×1 topic
  36. End-of-Life Care1▲ 11×2 topics
  37. Health Disparities1▲ 8.2×3 topics
  38. Medical Ethics1▲ 9.7×3 topics
  39. Patient Rights1▲ 17×2 topics
  40. Social Innovation1▲ 13×1 topic

Which research topics does Rijksinstituut voor Ziekte- en Invaliditeitsverzekering publish most on?

By volume in 2022–2025: Social Sciences and Governance, Health Systems, Economic Evaluations, Quality of Life, Health Literacy and Information Accessibility and Pharmaceutical Economics and Policy.

  1. 1 Social Sciences and Governance Urban Studies 1 works
  2. 2 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  3. 3 Health Literacy and Information Accessibility General Health Professions 1 works
  4. 4 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  5. 5 Healthcare Systems and Public Health Epidemiology 0 works
  6. 6 Human Health and Disease Pediatrics, Perinatology and Child Health 0 works
  7. 7 Social Media in Health Education Health 0 works
  8. 8 Natural Resources and Economic Development General Economics, Econometrics and Finance 0 works
  9. 9 Central European Literary Studies Anthropology 0 works
  10. 10 Language and Culture Linguistics and Language 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.4%not open52.6%

World: 28% of research is openly available.

with international co-authors29.8%domestic only70.2%

World: 19% is written across borders.

How has Rijksinstituut voor Ziekte- en Invaliditeitsverzekering's research output changed?

Output in 2018–2022 was 41% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Brussels

All research institutions in Brussels

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.